Market Place
Sourcing Support
Lilly opens phase 3 trial in RET-mutant medullary thyroid cancer
31 Dec 2019 //
PHARMABIZ
Inside drugmakers` strategy to boost cancer medicines with `Lazarus effect`
06 Sep 2019 //
REUTERS
Shrinking 60% of lung cancers, Blueprint`s RET drug poised for 2020 filing
04 Jun 2019 //
FIERCE BIOTECH
As Lilly deal closes, Bayer secures full rights to Loxo`s Vitrakvi
16 Feb 2019 //
BIOPHARMA DIVE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.